brainjo
Healthtech · Regensburg, DE
Terapia VR prescrivibile (DiGA) per bambini con ADHD.
Funding history
| Date | Round | Amount |
|---|
| Apr 2026 | Seed Germany's brainjo closed a EUR 2M seed led by HTGF for clinical studies and regulatory approval of its VR therapy for childhood ADHD. | $2.3M |
Investors
Andreas WeinhutHigh-Tech Gruenderfondsbetter ventures
Similar companies in Healthtech
Explore funding flow on EquityFlow →